ALCOA+ and Data Integrity

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-03-15-2020
Volume 2020 eBook
Issue 1
Pages: 10-13

Data supporting the quality and safety of product must meet the ALCOA+ elements in order to avoid regulatory citations for data integrity issues.

Data supporting the quality and safety of product must meet the ALCOA+ elements in order to avoid regulatory citations for data integrity issues.

Read this article in Pharmaceutical Technology’s March 2020 Regulatory Sourcebook.

Article Details

Pharmaceutical Technology
eBook: Regulatory Sourcebook, March 2020
March 2020
Pages: 10–13

Citation

When referring to this article, please cite it as S. J. Schniepp, “ALCOA+ and Data Integrity," Pharmaceutical Technology Regulatory Sourcebook eBook (March 2020).

 

 

Articles in this issue
Guidelines_225.jpg
Resources, Guidelines, and Guidance Documents
Orgs_225.jpg
Regulatory and Standard Setting Organizations
PTebook0320_004-005_RegulatoryActionUpdate_Peters.gif
A ‘New Normal’ for Quality?
Pharmacopoeia 1_225.jpg
Monograph Development: Why and When to Participate (eBook)
Pharmacopoeia 3_225.jpg
Pharmacopoeia Compliance: Putting It All Together; What Is on the Horizon (eBook)
Pharmacopoeia 2_225.jpg
A Practical Approach to Pharmacopoeia Compliance (eBook)
PTebook_cellandgene.jpg
Inside FDA’s New Gene and Cell Therapy Guidances
PT ebook_ALCOA.jpg
ALCOA+ and Data Integrity
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Grants Fast Track Designation to Q32 Bio Treatment for Alopecia Areata

Patrick Lavery
April 30th 2025
Article

Bempikibart (ADX-914) is a human anti-IL-7Rα antibody that blocks the IL-7 and TSLP pathways, which have been implicated in driving T cell-mediated pathological processes in autoimmune diseases.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

CARBOGEN AMCIS Shanghai Site Gets Drug Manufacturing License from China’s NMPA

Patrick Lavery
April 24th 2025
Article
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Bavarian Nordic Chikungunya Vaccine Recommended by CDC's ACIP

Patrick Lavery
April 18th 2025
Article

The recombinant vaccine, under the brand name Vimkunya, is recommended for persons age 12 and older who are traveling to a country or territory where there is a chikungunya outbreak.

compounding pharmacist at work 2 | Image Credit: ©Nadia -stock.adobe.com

Pharmaceutical Compounding Calculations, Part One–Non-Salts, Salts, and Policy-Exception Salts

Paul L. Pluta;Nishant B. Thakar;Varanya Chaiyaperm
April 18th 2025
Article

Calculating the amount of drug needed for compounding requires different considerations for respective drug types and forms.